Literature DB >> 1938703

The clinical presentation and diagnosis of invasive fungal infections.

G Maartens1, M J Wood.   

Abstract

The frequency of invasive fungal infections is increasing owing to the increasing numbers and improved survival of immuno-compromised patients. The fungi responsible for these infections are predominantly opportunistic pathogens. The clinical features and diagnosis of the four commonest infections (invasive candidosis and aspergillosis, cryptococcosis and mucormycosis) are discussed. Particular emphasis is given to the identification of risk factors for these infections, which are different for each disease. As these organisms are common contaminants or commensals, definitive diagnosis requires culture from sites that are normally sterile or histological demonstration of tissue invasion. Definitive diagnosis is not always possible, in part owing to the severe nature of patients' underlying illnesses. A high proportion of cases are diagnosed post mortem because of difficulties in establishing a diagnosis. Clinical diagnoses thus need to be made early in the course of these infections, but a high index of suspicion and knowledge of the clinical manifestations are required.

Entities:  

Mesh:

Year:  1991        PMID: 1938703     DOI: 10.1093/jac/28.suppl_a.13

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Invasive pulmonary aspergillosis: a rare presentation of non-Hodgkin's lymphoma.

Authors:  M Garcia-Gonzalez; A L Sanroman; R Arribas; G Torres; C Cuesta; V F Moreira
Journal:  Postgrad Med J       Date:  1994-06       Impact factor: 2.401

2.  COVID-19-Associated Mucormycosis in Diabetic Patients: The Tip of an Iceberg.

Authors:  Amirhossein Parsaei; Ashkan Mohammadi Kooshki; Hamid Nasri; Shakiba Hassanzadeh
Journal:  Iran J Public Health       Date:  2022-02       Impact factor: 1.479

Review 3.  Oral Mucormycosis: An Inevitable Complication of COVID-19.

Authors:  Madhura Dattatraya Kulkarni; Saakshi Gulati; Shivangi Gupta; Robin Sabharwal; Jagadish P Rajguru; Abishek Baneerjee
Journal:  J Family Med Prim Care       Date:  2022-05-14

4.  Clinical features, diagnosis, and outcomes of rhino-orbito-cerebral mucormycosis- A retrospective analysis.

Authors:  A Abdollahi; T Shokohi; N Amirrajab; R Poormosa; A M Kasiri; S J Motahari; S M Ghoreyshi; S A Madani; M Nikkhah; M Ghasemi; L Vahedi Larijani; M Didehdar; Z Seifi; N Gholinejad; M Ilkit
Journal:  Curr Med Mycol       Date:  2016-12

Review 5.  Mucormycosis in COVID-19 patients: predisposing factors, prevention and management.

Authors:  Pavan Kumar Rudrabhatla; Aravind Reghukumar; Sanjeev V Thomas
Journal:  Acta Neurol Belg       Date:  2021-11-24       Impact factor: 2.471

6.  Comparing the Characteristics of Mucormycosis Between Cases with and without COVID-19; a Cross-sectional Study.

Authors:  Mohammad Sistanizad; Mohammad Haji Aghajani; Mehrdad Haghighi; Hossein Amini; Asma Pourhoseingholi; Niloufar Taherpour; Shadi Ziaie; Sara Salarian; Omid Moradi
Journal:  Arch Acad Emerg Med       Date:  2022-07-12

Review 7.  New insights on mucormycosis and its association with the COVID-19 pandemic.

Authors:  Mona G Alshahawey; Ghadir S El-Housseiny; Noha S Elsayed; Mohammad Y Alshahrani; Lamia Mel Wakeel; Khaled M Aboshanab
Journal:  Future Sci OA       Date:  2021-12-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.